Browsing by Subject "tamoxifen"

Now showing items 1-3 of 3

    • Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics 

      Kheirelseid, Elrasheid A. H.; Jumustafa, Hanzali; Miller, Nicola; Curran, Catherine; Sweeney, Karl; Malone, Carmel; McLaughlin, Ray; Newell, John; Kerin, Michael J. (Springer Nature, 2010-07-28)
      There has been conflicting evidence on the impact of bilateral breast cancer (BBC) on the survival and management of patients. The objectives of this study were to address the incidence of BBC and to investigate its ...

    • S100β as a serum marker in endocrine resistant breast cancer 

      Charmsaz, Sara; Hughes, Éamon; Bane, Fiona T.; Tibbitts, Paul; McIlroy, Marie; Byrne, Christopher; Cocchiglia, Sinéad; McBryan, Jean; Hennessy, Bryan T.; Dwyer, Róisín M.; Kerin, Michael J.; Hill, Arnold D.; Young, Leonie S. (Springer Nature, 2017-04-12)
      Background: Endocrine therapy is standard treatment for estrogen receptor (ER)-positive breast cancer. However, its efficacy is limited by intrinsic and acquired resistance. Here the potential of S100 beta as a biomarker ...

    • The effect of menopause and hysterectomy on systemic vascular endothelial growth factor in women undergoing surgery for breast cancer 

      Lowery, Aoife J; Sweeney, Karl J; Molloy, Alan P; Hennessy, Emer; Curran, Catherine; Kerin, Michael J (Springer Nature, 2008-09-30)
      Background: Vascular endothelial growth factor (VEGF) is a potent angiogenic cytokine produced physiologically by the uterus. Pathological secretion by tumours promotes growth and metastasis. High circulating VEGF levels ...